| Syndecan-1 staining (percentage of tumors in brackets) | ||||
---|---|---|---|---|---|
 | 0 | 1+ | 2+ | 3+ |  |
 | n = 38 (29%) | n = 27 (21%) | n = 49 (37%) | n = 17 (13%) | p |
Variable | Â | Â | Â | Â | Â |
Age | Â | Â | Â | Â | 0.651 |
   <65 yrs | 16 (42.1) | 12 (44.4) | 17 (34.7) | 6 (35.3) |  |
   ≥ 65 yrs | 22 (57.9) | 15 (55.6) | 32 (65.3) | 11 (64.7) |  |
Gender | Â | Â | Â | Â | 0.042* |
   Male | 24 (63.2) | 22 (81.5) | 23 (46.9) | 10 (58.8) |  |
   Female | 14 (36.8) | 5 (18.5) | 26 (53.1) | 7 (41.2) |  |
Stage | Â | Â | Â | Â | 0.045* |
   I/II | 14 (36.8) | 13 (48.1) | 33 (67.3) | 9 (52.9) |  |
   III/IV | 24 (63.2) | 14 (51.9) | 16 (32.7) | 8 (47.1) |  |
Lymph node metastasis | Â | Â | Â | Â | 0.017* |
   negative | 16 (42.1) | 14 (51.9) | 36 (73.5) | 12 (70.6) |  |
   positive | 22 (57.9) | 13 (48.1) | 13 (26.5) | 5 (29.4) |  |
Location | Â | Â | Â | Â | 0.380 |
   Proximal | 13 (34.2) | 9 (33.3) | 13 (26.5) | 2 (11.8) |  |
   Distal | 25 (65.8) | 18 (66.7) | 36 (73.5) | 15 (88.2) |  |